Cargando…

Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer

Immune checkpoint inhibitors can affect any organ, including the salivary glands. A case of Sjögren's syndrome (SjS) induced by nivolumab for the treatment of gastric cancer is herein presented. Nivolumab treatment caused marked tumor shrinkage, but xerostomia developed after two cycles. It too...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higashi, Tetsuo, Miyamoto, Hideaki, Yoshida, Ryoji, Furuta, Yoki, Nagaoka, Katsuya, Naoe, Hideaki, Naito, Hisaki, Nakayama, Hideki, Tanaka, Motohiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662059/ https://www.ncbi.nlm.nih.gov/pubmed/32581160 http://dx.doi.org/10.2169/internalmedicine.4701-20

Ejemplares similares

Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis
por: Furuta, Yoki, et al.
Publicado: (2020)

Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the gallbladder and review of the literature
por: Honda, Munenori, et al.
Publicado: (2017)

Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma
por: Narahara, Satoshi, et al.
Publicado: (2021)

Mixed Neuroendocrine Non-Neuroendocrine Neoplasm Arising in the Ectopic Gastric Mucosa of Esophagus
por: Gushima, Ryosuke, et al.
Publicado: (2022)

Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment
por: Furuta, Yoki, et al.
Publicado: (2023)

Risk stratification of advanced colorectal neoplasia after baseline colonoscopy: Cohort study of 17 Japanese community practices
por: Shono, Takashi, et al.
Publicado: (2019)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Immune-related adverse events and prognosis in patients with upper gastrointestinal cancer treated with nivolumab
por: Hara, Yoshihiro, et al.
Publicado: (2022)

Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study
por: Tateyama, Masakuni, et al.
Publicado: (2020)

Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab
por: Mizutani, Kosuke, et al.
Publicado: (2021)

Preoperative Diagnosis of Intestinal Endometriosis by Magnifying Colonoscopy and Target Biopsy
por: Tomiguchi, Jun, et al.
Publicado: (2017)

Adverse events induced by nivolumab and ipilimumab combination regimens
por: Somekawa, Kohei, et al.
Publicado: (2022)

Clinical usefulness of inside stents in anastomotic biliary strictures after liver transplantation
por: Kugiyama, Naotaka, et al.
Publicado: (2023)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
por: Zhao, Bin, et al.
Publicado: (2019)

Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report
por: Miyauchi, Yasuyuki, et al.
Publicado: (2021)

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
por: Zhou, Shi, et al.
Publicado: (2019)

Severe eosinophilia and subsequent dermatologic immune‐related adverse event with squamous cell carcinoma antigen elevation induced by nivolumab and ipilimumab
por: Matsumoto, Takeshi, et al.
Publicado: (2022)

Impact of retroflexion in the right colon after repeated forward‐view examinations
por: Miyamoto, Hideaki, et al.
Publicado: (2018)

Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma
por: Segawa, Takuya, et al.
Publicado: (2023)

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
por: Masuda, Ken, et al.
Publicado: (2019)

Silkworm model for Bacillus anthracis infection and virulence determination
por: Paudel, Atmika, et al.
Publicado: (2021)

Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report
por: Sakoh, Takashi, et al.
Publicado: (2019)

Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies
por: Les, Iñigo, et al.
Publicado: (2021)

Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma
por: Gautron Moura, Bianca, et al.
Publicado: (2022)

Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan
por: Kanbayashi, Yuko, et al.
Publicado: (2023)

Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes
por: Fujiu, Koichi, et al.
Publicado: (2019)

Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies
por: Honda, Munenori, et al.
Publicado: (2021)

Narrow‐band imaging with magnification for the diagnosis of colorectal adenoma in a patient with Cronkhite‐Canada syndrome
por: Fukase, Hitoshi, et al.
Publicado: (2023)

Upstream sequence-dependent suppression and AtxA-dependent activation of protective antigens in Bacillus anthracis
por: Toyomane, Kochi, et al.
Publicado: (2019)

Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events
por: Imafuku, Keisuke, et al.
Publicado: (2017)

Rare Adverse Events Related to Nivolumab, an Immune Checkpoint Inhibitor: A Case Series
por: Ganta, Nagapratap, et al.
Publicado: (2022)

Risk of Adverse Events in Cancer Patients Receiving Nivolumab With Ipilimumab: A Meta-Analysis
por: Zhao, Xin, et al.
Publicado: (2022)

Two cases of delayed onset of immune‐related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer
por: Nakai, Yasutomo, et al.
Publicado: (2021)

Rheumatoid Arthritis Symptoms Diagnosed by Rheumatic Immune-related Adverse Events Caused by Nivolumab in a Patient with Esophageal Cancer
por: Yasui, Sho, et al.
Publicado: (2022)

Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab
por: Yamauchi, Ichiro, et al.
Publicado: (2019)

Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review
por: Dudzińska, Marta, et al.
Publicado: (2020)

Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer
por: Takada, Shinya, et al.
Publicado: (2022)

Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey
por: Oshima, Tsutomu, et al.
Publicado: (2018)

SUN-414 Immune Related Adverse Events: Isolated ACTH Deficiency with Nivolumab/Ipilimumab Combination Therapy
por: Magdaleno, Angela, et al.
Publicado: (2019)

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
por: Yoneda, Hiroto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_al440vh0tbjklv7hagbhmhja1l